BIOCRYST PHARMACEUTICALS INC
Ticker: 882796
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 156.41-1.9% | 159.40-2.4% | 163.35+12.2% | 145.53+24.3% | 117.09+7.1% | 109.33+17.9% | 92.76+6.9% | 86.74 |
| Total Income | 156.41-1.9% | 159.40-2.4% | 163.35+12.2% | 145.53+24.3% | 117.09+7.1% | 109.33+17.9% | 92.76+6.9% | 86.74 |
| EXPENSES | ||||||||
| Expenditure | 858.01+561.0% | 129.80-2.8% | 133.57+7.4% | 124.31+13.6% | 109.39+8.8% | 100.57-6.2% | 107.25+8.7% | 98.66 |
| Tax | 1.00+229.9% | -0.77-155.0% | 1.40+91.8% | 0.73+23.7% | 0.59+247.1% | 0.17-54.1% | 0.37+12.1% | 0.33 |
| PROFIT | ||||||||
| PBT | -720.81-6042.4% | 12.13+86.9% | 6.49+753.9% | 0.76+105.7% | -13.45-7.6% | -12.50+64.3% | -35.01+2.3% | -35.82 |
| Net Profit | -721.81-5695.4% | 12.90+153.4% | 5.09+16866.7% | 0.03+100.2% | -14.03-10.7% | -12.67+64.2% | -35.38+2.1% | -36.15 |
| KEY METRICS | ||||||||
| OPM % | -100.00%-118.56pp | 18.57%+0.33pp | 18.23%+3.65pp | 14.59%+8.02pp | 6.57%-1.44pp | 8.01%+23.63pp | -15.62%-1.88pp | -13.74% |
| NPM % | -100.00%-108.09pp | 8.09%+4.98pp | 3.11%+3.09pp | 0.02%+12.01pp | -11.98%-0.39pp | -11.59%+26.55pp | -38.14%+3.53pp | -41.67% |
| EPS | -2.98-5066.7% | 0.06+200.0% | 0.02 | 0.00+100.0% | -0.07-16.7% | -0.06+64.7% | -0.17+10.5% | -0.19 |
Corporate Events
Board MeetingBCRX
202611Jun
Board Meeting
Annual Meeting of Stockholders to elect directors, ratify au…
SEC Filing ↗